2. 筋萎縮性側索硬化症 Amyotrophic lateral sclerosis Clinical trials / Disease details

臨床試験数 : 624 / 薬物数 : 611 - (DrugBank : 160) / 標的遺伝子数 : 172 - 標的パスウェイ数 : 225

2 trials found

diseases per page:

Showing 1 to 2 of 2 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03359538 (ClinicalTrials.gov)	September 19, 2017	8/11/2017	Rapamycin Treatment for ALS	Rapamycin (Sirolimus) Treatment for Amyotrophic Lateral Sclerosis	Amyotrophic Lateral Sclerosis	Drug: Rapamycin;Drug: Placebo Oral Tablet	Azienda Ospedaliero-Universitaria di Modena	University of Modena and Reggio Emilia;Azienda Ospedaliero Universitaria Maggiore della Carita;IRCCS ...	Active, not recruiting	18 Years	75 Years	All	63	Phase 2	Italy
2	EUCTR2016-002399-28-IT (EUCTR)	14/07/2017	23/01/2018	Rapamycin (Sirolimus) treatment for amyotrophic lateral sclerosis	Rapamycin (Sirolimus) treatment for amyotrophic lateral sclerosis - RAP.ALS	definite or probable ALS MedDRA version: 20.0;Level: PT;Classification code 10002026;Term: Amyotroph ...	Trade Name: RAPAMUNE - 1 MG 100 COMPRESSE RIVESTITE IN BLISTER USO ORALE Product Name: Rapamune	AZIENDA OSPEDALIERO-UNIVERSITARIA POLICLINICO DI MODENA	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	63	Phase 2	Italy

First Previous1Next Last